Arrowstreet Capital, Limited Partnership Eiger Bio Pharmaceuticals, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$7.98 - $12.29 $332,853 - $512,628	-41,711 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$7.96 - $12.42 $409,605 - $639,108	-51,458 Reduced 55.23%	41,711 $340,000
Q2 2020 Aug 12, 2020	BUY	$5.4 - $13.37 $299,100 - $740,550	55,389 Added 146.61%	93,169 $894,000
Q1 2020 May 15, 2020	BUY	$4.91 - $14.7 $185,499 - $555,366	37,780 New	37,780 $257,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.